OOIR: Observatory of International Research

Papers

(The TQCC of JAMA Cardiology is 13. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-04-01 to 2025-04-01.)

Article	Citations
JAMA Cardiology	432
Sorrow on the Shoreline	262
Equity in Clinical Trial Participation Requires Equity in Identification and Treatment of Valvular Heart Disease	253
JAMA Cardiology	246
How Do We Credit the Evidence Generated From Subgroup Analyses in Randomized Clinical Trials?—Reply	219
No Diagnostic Concerns With Cardiovascular Magnetic Resonance Imaging in Patients With Breast Cancer and Breast Implants	209
Error in Abstract Results Section	202
A Child With Heart Failure and Bumpy Lesions on the Back	183
Serum Monocyte-Chemoattractant Protein–1 Could Be an Indicator of Coronary Artery Calcium Score—Reply	171
JAMA Cardiology	170
To Occlude or Not to Occlude the Left Atrial Appendage in Women—Reply	165
Screening the Older Population for Atrial Fibrillation—Have We Moved the Needle Forward?	161
Role of Income-Lifting Social Programs in Reducing Years of Life Lost to Myocardial Infarction and Sudden Death—Reply	151
Balancing Concerns—AI and Moral Agency in Medicine	150
New Right Atrial Image After Coronary Revascularization Surgery	149
Errors in Table 3	146
Persistent Opioid Use May Be a Failure of Pain Management Rather Than Prescribing—Reply	141
Simultaneous or Rapid Initiation of Combination Therapy for Heart Failure With Preserved Ejection Fraction	138
Errors in Numbers in the Text and Tables in a Secondary Analysis of the ISCHEMIA Randomized Clinical Trial	135
Transthyretin Tetramer Destabilization and Increased Mortality in the General Population	131
Deep Learning–Based Assessment of Built Environment From Satellite Images and Cardiometabolic Disease Prevalence	128
Nudging to Improve Cardiovascular Care—Clinicians, Patients, or Both	124
Myocardial Infarction and Evolocumab—Reply	123
More Attention Should Be Paid to Less Severe Nonculprit Lesions—Reply	115
A Teenager With Palpitations	115

JAMA Cardiology	115
JAMA Cardiology—The Year in Review, 2022	111
An Infant With Severe Heart Failure	109
A Man in His 30s With Splenic Infarct and Stroke	109
Educational Attainment and Cardiovascular Risk—A Missed Opportunity?	107
Screening for Rheumatic Heart Disease—Quo Vadis?	104
Plasma Proteomics of Exercise Blood Pressure and Incident Hypertension	102
Assessment of Oxygen Pulse in Hypertrophic Cardiomyopathy—Reply	99
Unusual Source of Dysphagia in a Man in His Eighth Decade of Life	96
Comments on the myPACE Randomized Clinical Trial	94
Michael Servetus, Doctor of Medicine	92
The “Power of Zero” in Younger Patients—A Glass Half Empty or a Glass Half Full?	91
JAMA Cardiology	91
Association of Baseline Low-Density Lipoprotein Cholesterol and Percentage Low-Density Lipoprotein Cholesterol Reduction With Statins, Ezetimibe, and PCSK9 Inhibition	88
Leadless Pacing—Uncertainties Remain About Safety and Efficacy—Reply	88
Knowing More Than the Knowns in Familial Hypercholesterolemia	87
JAMA Cardiology	84
JAMA Cardiology Peer Reviewers in 2023	82
Health and Economic Evaluation of Sacubitril-Valsartan for Heart Failure Management	81
Unusual Wide QRS Complex Rhythm in a Teenager	79
Smoking Cessation Improves Outcomes in Patients With Peripheral Artery Disease	78
Management of Severe and Moderate Hypercholesterolemia in Young Women and Men	76
Indigenous Representation and Belonging in Cardiology—Reply	76
The Balance Between Honesty and Hope	75
The Inglorious Art	73
JAMA Cardiology	72
Error in Diagnosis and Text	67
Role of Income-Lifting Social Programs in Reducing Years of Life Lost to Myocardial Infarction and Sudden Death	66
Culturally Adapted Lifestyle Intervention for South Asian Adults With Cardiovascular Risk Factors	66
Tailoring Risk Prediction Models to Local Populations	65
Association of COVID-19 Vaccination With Risk of COVID-19 Infection, Hospitalization, and Death in Heart Transplant Recipients	65
Recurrent Paravalvular Leak Following Mitral Valve Replacement	65
Association of Rare Genetic Variants and Early-Onset Atrial Fibrillation in Ethnic Minority Individuals	65
A Patient in His 50s With Chest Tightness and Left Arm and Neck Tingling	65
PCSK9 Inhibition—A Tale of 2 Potential Treatment Opportunities	64
Representation of Race and Ethnicity in the Contemporary US Health Cohort All of Us Research Program	64
A Man in His 60s With Pneumonia and Multiple Reintubation Attempts	64
Use the Receiver Operating Characteristic to Assess Model Accuracy—Reply	63
Errors in Table and Results Section	62
Biomarkers for Myocardial Infarction Type Discrimination—The Key Might Be in the Time Course of the Disease	61
JAMA Network Call for Papers on Health and the 2024 US Election	61
Regulatory Oversight of Cardiovascular Devices—Why We Care	60
Explanation of Error in “Effect of Brief Counseling by Allied Health Professionals on Step Count of People With Peripheral Artery Disease: A Randomized Clinical Trial”	60
Identifying Barriers to Initiation of Sodium-Glucose Cotransporter-2 Inhibitor Therapy in Patients Hospitalized With Heart Failure With Reduced Ejection Fraction—Reply	60
Pulsed Field Closes Gender Gap in Atrial Fibrillation Ablation—Electrifying Insights	60
JAMA Cardiology	59
Mendelian Randomization and Cardiovascular Disease—Enabling Expert Readership	59
The Longest Reported Outcomes of the Ross Procedure	59
Improving the Detection of ST-Segment Elevation Myocardial Infarction in Rural Settings	58
Factors Affecting Yield of Genetic Testing of Sudden Deaths in Young Individuals	58

Quality of Care and Clinical Outcomes for Patients With Heart Failure at Hospitals Caring for a High Proportion of Black Adults	58
Team-Based Digital Gamification to Improve Cardiovascular Health in Women With Hypertensive Disorders of Pregnancy—Reply	57
Anticipating Pharmacological Perturbation With Human Genetic Variation—Lessons From CETP	55
A Man in His 20s With Gradually Enlarging Mediastinal Mass and Intermittent Hemoptysis	55
Improving Quality Improvement—From Aspiration Toward Empiricism	54
JAMA Cardiology	53
Macular Degeneration and CETP Inhibition—Reply	53
Navigating Cardiology’s Leaky Pipeline	52
A Woman With Recurrent Syncope and Malar Flush in the Setting of a Left Atrial Echogenic Mass	52
Extrapolating Long-term Event-Free and Overall Survival With Dapagliflozin in Patients With Heart Failure and Reduced Ejection Fraction	51
Validating Deep Learning to Distinguish Takotsubo Syndrome From Acute Myocardial Infarction—Beware of Shortcuts, Human Supervision Required	50
Troubleshooting CardioMEMS After Implant—Failure to Read	50
A Woman With Recurrent Torsade de Pointes	50
Assessment of the Diagnostic Yield of Combined Cardiomyopathy and Arrhythmia Genetic Testing	49
USPSTF Report on Aspirin for Primary Prevention	49
Is There a Need for Palliative Care for Patients With Heart Failure With Preserved Ejection Fraction?	48
Association of Effective Regurgitation Orifice Area to Left Ventricular End-Diastolic Volume Ratio With Transcatheter Mitral Valve Repair Outcomes	48
Mitochondrial Respiration and Exercise Performance in Patients With Heart Failure With Preserved Ejection Fraction	47
Return-to-Play Guidelines for Athletes After COVID-19 Infection	47
Primary Prevention Management of Elevated Lipoprotein(a)	47
Effectiveness of Systematic Echocardiographic Screening for Rheumatic Heart Disease in Nepalese Schoolchildren	46
Consequences of Inaccurate Assumptions in Coronary Stent Noninferiority Trials	46
Clinical and Quality-of-Life Outcomes Following Invasive vs Conservative Treatment of Patients With Chronic Coronary Disease Across the Spectrum of Kidney Function	45
Safety, Feasibility, and Diagnostic Yield of Invasive Coronary Function Testing	45
A Young Woman With Viral Myocarditis	45
Electronic Nudges and Influenza Vaccination Among Patients With a History of Myocardial Infarction	45
Heterogeneity of Apolipoprotein B Levels Among Hispanic or Latino Individuals Residing in the US	44
Donning the Hijab—A Cardiology Fellow’s Journey With Advocacy and Inclusion	44
JAMA Cardiology	44
Intensive Blood Pressure Control in Older Adults	44
Chest Pain in a Middle-Aged Man	43
Distinct Genetic Risk Profile in Aortic Stenosis Compared With Coronary Artery Disease	43
Early-Onset Atrial Fibrillation and Heritable Heart Disease—To Test or Not to Test?	42
Behind the Hospital Curtain	42
The Case for Inclusion of a Lipid Panel in the Standard Precatheterization Laboratory Blood Draw—Stating What Should Be Obvious	42
Error in Table 1	42
Advancing Data Collection of Sexual Orientation and Gender Identity in Cardiology	42
Man in His Sixth Decade of Life With Totally Occluded Abdominal Aorta (Leriche Syndrome)	42
Education and Information to Improve Cardiovascular Health	42
Childhood Parental Incarceration and Adult-Onset Hypertension and Cardiovascular Risk	41
Emergency Medical Service Agency Practices and Cardiac Arrest Survival	41
Association of Cardiac Biomarkers With Major Adverse Cardiovascular Events in High-risk Patients With Diabetes	41
Assessing the Role of Rare Genetic Variation in Patients With Heart Failure	41
Recurrent Chest Pain in a Young Female Patient With Family History of Cancer	40
Genius and the CVD Polypill—A Step Toward Achieving Health Equity?	40
Patient Enrollment for Cardiovascular Clinical Trials in the United States	40
Artificial Intelligence–Enhanced Electrocardiography for Prediction of Incident Hypertension	39
Novel Controlled Metabolic Accelerator for Obesity-Related HFpEF	39
Trajectory of Cardiovascular Health Across Childhood and Adolescence	38
Diversity in Clinical Trial Enrollment and Reporting—Where We Are and the Road Ahead	38
Causative Mechanism of Constrictive Pericarditis Diagnosed by Fluoroscopy	38
JAMA Cardiology	37
A Man in His 30s With Ponytail Coronary Artery Anomaly	37
Association of Novel Locus With Rheumatic Heart Disease in Black African Individuals	37
JAMA Cardiology Peer Reviewers in 2024	37
A Pathway to Better Blood Pressure Control	37
Long-term Clinical and Echocardiographic Outcomes in Young and Middle-aged Adults Undergoing the Ross Procedure	37
Multifaceted Intensive Blood Pressure Control Model in Older and Younger Individuals With Hypertension	35
Exercise and Resistant Hypertension—Is Exercise Enough?	35
Large-Scale Proteomics in Early Pregnancy and Hypertensive Disorders of Pregnancy	35
Clopidogrel Monotherapy for Double-Risk Acute Coronary Syndrome	35
Realigning Priorities in the Evaluation and Management of Patients With Heart Failure	35
Genome-Wide Association Study of Accessory Atrioventricular Pathways	34
Addressing Lifestyle Patterns Among South Asian Individuals in the US	33
Evaluation for Myocarditis in Competitive Student Athletes Recovering From Coronavirus Disease 2019 With Cardiac Magnetic Resonance Imaging	33
Sudden Hemodynamic Deterioration of a 75-Year-Old Woman With Progressive Jaw Pain	33
Sex-Related Disparities in Cardiovascular Health Care Among Patients With Premature Atherosclerotic Cardiovascular Disease	33
Outcomes of Patients With Catecholaminergic Polymorphic Ventricular Tachycardia Treated With β-Blockers	32
Parsing Signal vs Noise—Secondary Analyses of RCTs	32
The Fine Art and Science of Translating Trials Results Into Clinical Practice	32
Sex Differences in Atrial Fibrillation Risk	31
Association of Serial High-Sensitivity Cardiac Troponin T With Subsequent Cardiovascular Events in Patients Stabilized After Acute Coronary Syndrome	31
Implementing Shared Decision-making for Patients With Aortic Stenosis With Longer Life Expectancy	31
Ventricular Septal Rupture After ST-Segment Elevation Myocardial Infarction	31
Competing Risks, Treatment Switching, and Informative Censoring	31
Prevalence, Cardiac Phenotype, and Outcomes of Transthyretin Variants in the UK Biobank Population	30
Global Impact of Optimal Implementation of Guideline-Directed Medical Therapy in Heart Failure	30
Midlife Wealth Mobility and Long-term Cardiovascular Health	30
Lesion-Level Effects of LDL-C–Lowering Therapy in Patients With Acute Myocardial Infarction	30
Comparison of Long-term Clinical Outcomes of Skeletonized vs Pedicled Internal Thoracic Artery Harvesting Techniques in the Arterial Revascularization Trial	30

Deep Learning for Cardiovascular Imaging	30
Use of Lipid-Lowering Therapies Over 2 Years in GOULD, a Registry of Patients With Atherosclerotic Cardiovascular Disease in the US	30
Effects of Mavacamten on Measures of Cardiopulmonary Exercise Testing Beyond Peak Oxygen Consumption	30
Association of Differences in Treatment Intensification, Missed Visits, and Scheduled Follow-up Interval With Racial or Ethnic Disparities in Blood Pressure Control	29
Interventions to Mitigate Risk of Cardiovascular Disease After Adverse Pregnancy Outcomes	29
Metabolomic Analysis of Coronary Heart Disease in an African American Cohort From the Jackson Heart Study	29
External Support for Saphenous Vein Grafts in Coronary Artery Bypass Surgery	29
Endurance Exercise Following Ascending Thoracic Aortic Aneurysm Resection in Bicuspid Aortic Valve Aortopathy	29
Factors Underlying Reduced Hospitalizations for Myocardial Infarction During the COVID-19 Pandemic	28
Hypoglycemia and Cardiovascular Outcomes in the CARMELINA and CAROLINA Trials of Linagliptin	28
A Simplified Method for the Diagnosis of Constrictive Pericarditis in the Cardiac Catheterization Laboratory	28
Leadless Ultrasound-Based Cardiac Resynchronization System in Heart Failure	28
Association of Left Ventricular Systolic Function With Incident Heart Failure in Late Life	27
Diagnosis of Heart Failure With Preserved Ejection Fraction Among Patients With Unexplained Dyspnea	27
Cardiovascular Magnetic Resonance Imaging Phenotypes and Long-term Outcomes in Patients With Suspected Cardiac Sarcoidosis	27
Effectiveness of Home-Based Mobile Guided Cardiac Rehabilitation as Alternative Strategy for Nonparticipation in Clinic-Based Cardiac Rehabilitation Among Elderly Patients in Europe	27
Epicardial and Pericardial Fat—Separated But Under the Same Roof	27
Alerting Clinicians to 1-Year Mortality Risk in Patients Hospitalized With Heart Failure	27
Quantifying and Interpreting the Prediction Accuracy of Models for the Time of a Cardiovascular Event—Moving Beyond C Statistic	27
Skeletal Muscle Mitochondrial Respiration and Exercise Intolerance in Patients With Heart Failure With Preserved Ejection Fraction	27
Prasugrel Dose De-escalation Therapy After Complex Percutaneous Coronary Intervention in Patients With Acute Coronary Syndrome	27
Aortic Valve Intervention for Asymptomatic Aortic Stenosis	27
Association of Longer Leukocyte Telomere Length With Cardiac Size, Function, and Heart Failure	26
Coronary Angiography After Out-of-Hospital Cardiac Arrest Without ST-Segment Elevation	26
Trends in 10-Year Outcomes Among Medicare Beneficiaries Who Survived an Acute Myocardial Infarction	26
Association of Circulating Monocyte Chemoattractant Protein–1 Levels With Cardiovascular Mortality	26
Predictive Utility of a Coronary Artery Disease Polygenic Risk Score in Primary Prevention	26
Association of Rurality With Risk of Heart Failure	26
Assessment of Neutrophil Extracellular Traps in Coronary Thrombus of a Case Series of Patients With COVID-19 and Myocardial Infarction	26
Potential Role and Limitations of Estimated Glomerular Filtration Rate Slope Assessment in Cardiovascular Trials	26
Fundamental Pathobiology of Coronary Atherosclerosis and Clinical Implications for Chronic Ischemic Heart Disease Management—The Plaque Hypothesis	25
Cardiopulmonary Exercise Testing in Evaluating Transthyretin Amyloidosis	25
Prevalence of Transthyretin Amyloid Cardiomyopathy in Heart Failure With Preserved Ejection Fraction	25
Self-expanding Transcatheter vs Surgical Aortic Valve Replacement in Intermediate-Risk Patients	24
Racial Disparities in Sports Cardiology	24
Dapagliflozin and Kidney Outcomes in Patients With Heart Failure With Mildly Reduced or Preserved Ejection Fraction	24
Finding Pulmonary Arterial Hypertension—Switching to Offense to Mitigate Disease Burden	24
Acute Myocardial Infarction Admissions During the COVID-19 Peak	23
Aspirin and Hemocompatibility After LVAD Implantation in Patients With Atherosclerotic Vascular Disease	23
Heart Failure—Together We Go Farther	23
Error in Byline	23
Leadless Ultrasound-Based Cardiac Resynchronization Therapy	23
Catheter-Directed Thrombolysis vs Anticoagulation in Patients With Acute Intermediate-High–risk Pulmonary Embolism	23
Artificial Intelligence–Guided Lung Ultrasound by Nonexperts	23
Can Noncalcified Plaques Contribute to Future Coronary Events?—Reply	22
Hard Lessons From a School-Based Intervention to Improve Cardiovascular Health in Adolescence	22
Lipoprotein(a), Menopausal Hormone Therapy, and Risk of Coronary Heart Disease in Postmenopausal Individuals	22
Variants at the Interleukin 1 Gene Locus and Pericarditis	22
Time to Revisit Using 10-Year Risk to Guide Statin Therapy	22
Asundexian or Apixaban in Patients With Atrial Fibrillation According to Prior Oral Anticoagulant Use	22
Precision Medicine for Hypertensive Disorders of Pregnancy—Are We There Yet?	21
High-Intensity Interval Training vs Moderate-Intensity Continuous Training for Women Undergoing Cardiovascular Rehabilitation	21
Women’s Representation in Interventional Cardiology	21
JAMA Cardiology	21
As Old Cardiologists Fade Away	21
Could Neprilysin Be Already Inhibited by BNP in the LIFE Trial?—Reply	21
Wide Complex Tachycardia in a Middle-Aged Woman With Diarrhea	21
What Is Your Secret to Health?	21
Defining Rural in Rural-Urban Differences in Myocardial Infarction Management—Reply	21
Contribution of Clinical Trial Event Data by Data Source	21
Error in Author Name	21
Assessment of the Change of a Continuous Variable as a Function of its Initial Value	20
JAMA Cardiology—The Year in Review, 2020	20
Benefit of Implantable Cardioverter-Defibrillators in Patients With Catecholaminergic Polymorphic Ventricular Tachycardia—Reply	20
Hypertriglyceridemia in the MESA Study—Reply	20
Error in Affiliations	20
Persistent Opioid Use May Be a Failure of Pain Management Rather Than Prescribing	20
Authenticity—An Uphill Battle for a Black Woman in Cardiology	20
Reporting Genetic Markers and the Social Determinants of Health in Clinical Cardiovascular Research—It Is Time to Recalibrate the Use of Race	20
Clinical Utility of Lipoprotein(a) for Screening Does Not Determine Clinical Utility of Lipoprotein(a) for the Patient	20
No Diagnostic Concerns With Cardiovascular Magnetic Resonance Imaging in Patients With Breast Cancer and Breast Implants—Reply	19
Assisted Reproductive Technologies and Cardiovascular Disease Risk in Birthing Adults—When Null Results Matter	19
Influenza Vaccine Immune Response in Patients With High-Risk Cardiovascular Disease	19
Assessing Performance of Machine Learning—Reply	19
National Trends in Heart Failure Hospitalization and Readmissions Associated With Policy Changes—Reply	19
Out-of-Hospital Cardiac Arrest—One Size Does Not Fit All	19
Myocardial Infarction and Evolocumab	19
Spontaneous Coronary Artery Dissection in a Healthy Man With Non–ST Elevation Myocardial Infarction	19
National Trends in Heart Failure Hospitalization and Readmissions Associated With Policy Changes	19
Troponins and Pregnancy	19
A Middle-aged Man With Sharp Chest Pain	19
Woman in Her 50s With Pulmonary Hypertension Associated With Takayasu Arteritis	18
Error in Author Name	18
Further Characterizing Cardiomyopathy Mortality in Young Adults to Elucidate Health Disparities	18
Dual Antiplatelet Therapy De-Escalation in Stabilized Myocardial Infarction With High Ischemic Risk	18
Beware the Possible Dangers of Chemsex—Is Illicit Drug–Related Sudden Cardiac Death Underestimated?	18
Error in Supplement	18
JAMA Cardiology	18
Supraventricular Tachycardia Following Mitral Valve Surgery	18
Further Characterizing Cardiomyopathy Mortality in Young Adults to Elucidate Health Disparities—Reply	18
Erroneous Rapid Exchange Balloon Inflation During Coronary Angioplasty in a Male Patient in His 70s With Chronic Stable Angina	17
Automated Assessment of Cardiac Systolic Function From Coronary Angiograms With Video-Based Artificial Intelligence Algorithms	17
Addressing Imaging Pitfalls to Reduce Cardiovascular Disease Misdiagnosis in Patients With Breast Cancer Following Reconstruction	17
Role of Coronary Artery Calcium Testing for Risk Assessment in Primary Prevention of Atherosclerotic Cardiovascular Disease	17
The Role of Posterior Wall Isolation in Catheter Ablation for Persistent Atrial Fibrillation and Systolic Heart Failure	17